287 related articles for article (PubMed ID: 16597468)
21. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
Datta AK; Datta R; Sen B
Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
[TBL] [Abstract][Full Text] [Related]
22. Involvement of a Leishmania thymidine kinase in flagellum formation, promastigote shape and growth as well as virulence.
Thiel M; Harder S; Wiese M; Kroemer M; Bruchhaus I
Mol Biochem Parasitol; 2008 Apr; 158(2):152-62. PubMed ID: 18222009
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: a possible role of virulence molecules (gp63 and LPG).
Chakrabarty R; Mukherjee S; Lu HG; McGwire BS; Chang KP; Basu MK
J Parasitol; 1996 Aug; 82(4):632-5. PubMed ID: 8691373
[TBL] [Abstract][Full Text] [Related]
24. Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics.
Debrabant A; Joshi MB; Pimenta PF; Dwyer DM
Int J Parasitol; 2004 Feb; 34(2):205-17. PubMed ID: 15037106
[TBL] [Abstract][Full Text] [Related]
25. A Leishmania donovani gene that confers accelerated recovery from stationary phase growth arrest.
Hoyer C; Zander D; Fleischer S; Schilhabel M; Kroener M; Platzer M; Clos J
Int J Parasitol; 2004 Jun; 34(7):803-11. PubMed ID: 15157763
[TBL] [Abstract][Full Text] [Related]
26. Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation.
Pescher P; Blisnick T; Bastin P; Späth GF
Cell Microbiol; 2011 Jul; 13(7):978-91. PubMed ID: 21501362
[TBL] [Abstract][Full Text] [Related]
27. Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani.
Saar Y; Ransford A; Waldman E; Mazareb S; Amin-Spector S; Plumblee J; Turco SJ; Zilberstein D
Mol Biochem Parasitol; 1998 Sep; 95(1):9-20. PubMed ID: 9763285
[TBL] [Abstract][Full Text] [Related]
28. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
[TBL] [Abstract][Full Text] [Related]
29. One-step generation of double-allele gene replacement mutants in Leishmania donovani.
Ommen G; Lorenz S; Clos J
Int J Parasitol; 2009 Apr; 39(5):541-6. PubMed ID: 19028498
[TBL] [Abstract][Full Text] [Related]
30. [Adenine phosphoribosyltransferase and hypoxanthine phosphoribosyltransferase of blood platelets in hereditary coagulopathies].
Sokovnina IaM; Mareeva TB; Pliushch OP; Votrin II
Vopr Med Khim; 1985; 31(5):114-7. PubMed ID: 4090355
[TBL] [Abstract][Full Text] [Related]
31. Infectivity and attenuation of Leishmania donovani promastigotes: association of galactosyl transferase with loss of parasite virulence.
De T; Roy S
J Parasitol; 1999 Feb; 85(1):54-9. PubMed ID: 10207363
[TBL] [Abstract][Full Text] [Related]
32. Localization and targeting of the Leishmania donovani hypoxanthine-guanine phosphoribosyltransferase to the glycosome.
Shih S; Hwang HY; Carter D; Stenberg P; Ullman B
J Biol Chem; 1998 Jan; 273(3):1534-41. PubMed ID: 9430693
[TBL] [Abstract][Full Text] [Related]
33. Crystallization of the purine salvage enzyme adenine phosphoribosyltransferase.
Phillíps CL; Ullman B; Brennan RG
Proteins; 1996 Aug; 25(4):510-3. PubMed ID: 8865346
[TBL] [Abstract][Full Text] [Related]
34. Genetic analysis of adenine metabolism in Leishmania donovani promastigotes. Evidence for diploidy at the adenine phosphoribosyltransferase locus.
Iovannisci DM; Goebel D; Allen K; Kaur K; Ullman B
J Biol Chem; 1984 Dec; 259(23):14617-23. PubMed ID: 6501311
[TBL] [Abstract][Full Text] [Related]
35. Adenine phosphoribosyltransferase in patients with disorders of purine and pyrimidine metabolism.
Wilson JM; Daddona PE; Otoadese T; Kelley WN
J Lab Clin Med; 1982 Feb; 99(2):163-74. PubMed ID: 7061917
[TBL] [Abstract][Full Text] [Related]
36. IMP dehydrogenase deficiency in Leishmania donovani causes a restrictive growth phenotype in promastigotes but is not essential for infection in mice.
Fulwiler AL; Boitz JM; Gilroy C; Yates PA; Jardim A; Ullman B
Mol Biochem Parasitol; 2011 Dec; 180(2):123-6. PubMed ID: 21907738
[TBL] [Abstract][Full Text] [Related]
37. Crystal structures of adenine phosphoribosyltransferase from Leishmania donovani.
Phillips CL; Ullman B; Brennan RG; Hill CP
EMBO J; 1999 Jul; 18(13):3533-45. PubMed ID: 10393170
[TBL] [Abstract][Full Text] [Related]
38. Selection for purine regulatory mutants in an E. coli hypoxanthine phosphoribosyl transferase-guanine phosphoribosyl transferase double mutant.
Levine RA; Taylor MW
Mol Gen Genet; 1981; 181(3):313-8. PubMed ID: 6787390
[TBL] [Abstract][Full Text] [Related]
39. Leishmania histone H1 overexpression delays parasite cell-cycle progression, parasite differentiation and reduces Leishmania infectivity in vivo.
Smirlis D; Bisti SN; Xingi E; Konidou G; Thiakaki M; Soteriadou KP
Mol Microbiol; 2006 Jun; 60(6):1457-73. PubMed ID: 16796681
[TBL] [Abstract][Full Text] [Related]
40. Localization and induction of the A2 virulence factor in Leishmania: evidence that A2 is a stress response protein.
McCall LI; Matlashewski G
Mol Microbiol; 2010 Jul; 77(2):518-30. PubMed ID: 20497497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
